InvestorsHub Logo
Followers 21
Posts 1197
Boards Moderated 0
Alias Born 05/06/2014

Re: None

Sunday, 07/17/2016 6:34:16 PM

Sunday, July 17, 2016 6:34:16 PM

Post# of 38634
http://finance.yahoo.com/news/pfizer-walks-remoxy-end-ulterior-170000862.html

re: Remoxy - As of their last update earlier in 2014, Pfizer was still guiding to re-file the NDA around the middle of 2015. Today's news is a big disappointment. We had previously stated that REMOXY had potential peak sales in the $1.5 billion range. Durect's tiered royalty – roughly 9.1% at $1.5 billion in sales – would have provided significant cash flow to the company.

I'm going by memory so I may be off in my figures... but it's to give a better understanding of what exactly IPCI's potential is.

Note that royalty payments to Durect is almost 10% of SALES or an estimated $150 Million a year in PURE PROFIT.

Also note that Durect's deal is not with Pfizer but with Pain Therapeutics - who bought the rights to Remoxy from Durect for around $20 million??? + 9.1% which a few years later,.. after bringing it along a little further, Pain Therap. sold it to King pharma for I believe $400 million, + I think 20% royalty... and Pfizer bought out King primarily to get Remoxy... and then spent hundreds of millions more to bring it along, and eventually dropped it.

You all need to open your eyes wide and realize what exactly IPCI is about - sure it's a buck and a half NOW, but that doesn't mean that's what it's worth, and good investing is finding a bargain and going all in before everyone else discovers it.

For the umpteenth time - 20K shares today makes you a millionaire in 3 to 5 years.

WAKE THE HELL UP!!!!!!!!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPCI News